Navigation Links
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Date:10/4/2007

President of Commercial Operations at Tercica where he was responsible for developing and overseeing Tercica's global commercialization strategies and was intimately involved in the development and consummation of the Ipsen cross-licensing collaboration. As Senior Vice President, Genzyme Therapeutics, Mr. Rivera was largely responsible for building the company's U.S. renal business and assisted in the launch of Renagel(R) (sevelamer hydrochloride) globally. Earlier in his career, Mr. Rivera also helped build the initial commercial organizations at Centocor and Cephalon.

Marvin R. Garovoy, MD, Senior Vice President, Clinical Development, has held numerous industry positions over the past several years, including Vice President of Clinical Science at Xoma (US) LLC where he was the clinical lead working in collaboration with Genentech on the development of Raptiva(R) (efalizumab) from Phase I through FDA approval. Dr. Garovoy was most recently at Arriva Pharmaceuticals, where he held the position of Chief Medical Officer. Dr. Garovoy is a transplant physician by training, and has held multiple teaching positions at Harvard Medical School and at UCSF where he was Professor of Surgery, Medicine and Laboratory Medicine.

Sharron E. Gargosky, PhD, Chief Scientific Officer and Senior Vice President of Corporate Development, was most recently Executive Director of Ucyclyd, Research and Development at Ucyclyd Pharma Inc., a subsidiary of Medicis Pharmaceutical Corporation. In this role, she was responsible for the NDA approval of AMMONUL(R) (sodium phenylacetate and sodium benzoate) Injection 10%/10%. Dr. Gargosky was previously Vice President of Business Development for Diagnostic System Laboratories where she was responsible for business expansion through evaluation and implementation of new growth opportunities and patent portfolio management. Dr Gargosky's prior positions include Clinical Director for Pharmacia and Assistant Research Professor in the Endocrino
'/>"/>

SOURCE Hyperion Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... NC (PRWEB) September 19, 2014 ... Biobased Product Label for its Organic Cotton . ... product’s amount of renewable biobased ingredients meets or exceeds ... intermediate materials composed in whole or in significant part ... logo/label will allow our Organic cotton to be immediately ...
(Date:9/19/2014)... September 19, 2014 , The ... Society for Paediatric Endocrinology (ESPE) Meeting  Investment ... medical research in the field of growth  , ... Germany , today announced the first ... 2014. The awards were announced during a Satellite Symposium ...
(Date:9/18/2014)... 2014 HealthTronics, Inc ., ... radiology products and services, announced that a poster ... cryoablation) versus external beam radiotherapy (EBRT) is being ... Urological Association (MAAUA) Annual Meeting in Baltimore, Maryland ... of Cryosurgery and External Beam Radiation as Treatments ...
(Date:9/18/2014)... Worcester, Mass. (PRWEB) September 18, 2014 ... bore of an MRI scanner is currently being tested ... Brigham and Women's Hospital in Boston with the aim ... MRI images, can make prostate cancer biopsies faster, more ... The novel system also has the potential to deliver ...
Breaking Biology Technology:Barnhardt Manufacturing Company Earns USDA Certified Biobased Product Certification and Label for Organic Cotton 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3HealthTronics Announces Data Comparing Cryotherapy Versus Radiation for Treating Prostate Cancer Poster Presented at the American Urological Association Regional Meeting 2Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 2Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 4Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 5Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 6
... the National Institute of Standards and Technology (NIST) ... new type of computer memory now under development. ... George Mason University (GMU), aims to optimize nanowire-based ... creating portable computers and cell phones that can ...
... In a new study conducted at the Pennington Biomedical Research ... activity over the past fifty years is a significant contributor ... caloric intake cannot solely account for observed trends in weight ... The study, entitled "Trends Over 5 Decades in ...
... 25, 2011 Rules-Based Medicine (RBM), a global ... Psynova Neurotech, has achieved a significant milestone in ... samples from a Roche clinical trial, the RBM ... a biomarker pattern was identified that has utility ...
Cached Biology Technology:NIST 'nanowire' measurements could improve computer memory 2Pennington Biomedical Research Center Study Suggests Decreases in U. S. Occupation Energy Levels a Significant Trigger of Obesity Epidemic 2Pennington Biomedical Research Center Study Suggests Decreases in U. S. Occupation Energy Levels a Significant Trigger of Obesity Epidemic 3Rules-Based Medicine Reaches a Significant Milestone in Companion Diagnostic Program With Roche 2
(Date:9/18/2014)... SAN ANTONIO, September 18, 2014 New research into ... which causes a severe hemorrhagic disease in humans similar ... factors essential for CCHFV infection. This discovery has the ... against the pathogen. , The research, reported ... PLoS Pathogens and conducted by scientists at the ...
(Date:9/18/2014)... that prompts millions of Americans to undertake jaunts into the ... a little longer within a century, according to new research. ... areas of the United States as summer temperatures linger later ... Global Ecology and Biogeography . For instance, the paper ... tree of New Hampshire could change color one to ...
(Date:9/18/2014)... Va.Sept. 18, 2014Many Americans across racial and ethnic ... greatest impact on their day-to-day life, more so ... hearing and speech (57% of African-Americans, 49% of ... Hispanics). When asked which disease or ailment is ... ranked first among African-Americans followed by AIDS/HIV. ...
Breaking Biology News(10 mins):Research milestone in CCHF virus could help identify new treatments 2Fall foliage season may be later, but longer on warmer Earth 2Fall foliage season may be later, but longer on warmer Earth 3Fall foliage season may be later, but longer on warmer Earth 4Americans rate losing eyesight as having greatest impact on their lives 2Americans rate losing eyesight as having greatest impact on their lives 3
... the way carbon is counted in current U.S. climate legislation ... greenhouse gas emissions by using biofuels, says a premier group ... of biofuels made from biomass is huge, from both climate ... professor of crop and soil sciences and one of the ...
... Theodore Garland will give an hour-long lecture, titled ... p.m., Thursday, Oct. 29, in the University Theatre ... p.m. Seating is open. In his talk, Garland, a ... Riverside, will address the evolution of voluntary locomotor activity, some ...
... of Harvard chemists led by X. Sunney Xie has ... molecules with undetectable fluorescence. The room-temperature technique allows researchers ... offers broad applications in biomedical imaging and research. ... issue of Nature . Partial funding for the ...
Cached Biology News:Miscounting bioenergy benefits may increase greenhouse gas release 2Evolution of hyperactivity is focus of free public lecture at UC Riverside 2Seeing previously invisible molecules for the first time 2Seeing previously invisible molecules for the first time 3
... Rabbit polyclonal to MKK6 (phospho S207) ... applications). Antigen: ... around the phosphorylation site of Serine ... Entrez Gene ID: 5608 ...
Mouse monoclonal [1Q17] to TGE Virus peplomer ( Abpromise for all tested applications)....
CD45/CD34 combination 50 tests...
XPC Immunogen: XPC (NP_004619, 141 a.a. ~ 251 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: